Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory andKRASwild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status

✍ Scribed by Myoung Joo Kang, Yong Sang Hong, Kyu-pyo Kim, Sun Young Kim, Ji Yeon Baek, Min-Hee Ryu, Jae-Lyun Lee, Heung Moon Chang, Mi-Jung Kim, Hee Jin Chang, Yoon-Koo Kang, Tae Won Kim

• Book ID: 113064551
• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 166 KB
• Volume: 30
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-011-9703-8